Polfarma increased its stake in Russian pharma company
ID: 593734
(firmenpresse) - The joint-stock company Polfarma Pharmaceutical Factory increased its stake in OJSC Integrated Chemical and Pharmaceutical Enterprise Akrikin from 72.54% to 98.17%.
Akrikhin is the fifth largest local producer by revenue 2010 and one of the fastest growing pharmaceutical companies on the Russian market. The Akrikhin revenue in 2011 grew by almost 18% from 3. 609 billion Rub to 4.254 billion Rub.
Chameleon Pharma Consulting comments: During the last year Polfarma has already acquired a big share in a leading pharmaceutical factory in Kazakhstan. But it is difficult for the company to achieve substantial growth in Poland. With this idea Polfarma seems to follow a strategy to move east in order to grow further. We also observe that these are mostly the CEE companies, which enter growing countries like Kazakhstan. Unfortunately, Pharma Players from western markets often use their existing Russian or Ukrainian partner to handle countries like Kazakhstan. We, Chameleon Pharma, always recommend to have a single good performing partner in Kazakhstan and to handle this interesting market directly.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Chameleon Pharma Consulting is the healthcare and Pharma consulting expert for the CIS and Eastern European markets. Except for acquisition of targets and due diligence consulting, a part of the major business of Chameleon Pharma Consulting is the search for dynamic and highly-productive Healthcare sale and marketing partners on the CEE & GUS markets.
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
Germany
Tel: +49 30 648 35 163
Fax: +49 30 648 32 008
service(at)chameleon-pharma.com
www.chameleon-pharma.com
Ansprechpartner: Olga Kiefer
Tel: 030 648 35 164
E-mail: olki(at)chameleon-pharma.com
Datum: 12.03.2012 - 17:02 Uhr
Sprache: Deutsch
News-ID 593734
Anzahl Zeichen: 1143
Kontakt-Informationen:
Ansprechpartner: Olga Kiefer
Stadt:
Berlin
Telefon: 030 648 25164
Kategorie:
Pharma
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Diese Pressemitteilung wurde bisher 404 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Polfarma increased its stake in Russian pharma company "
steht unter der journalistisch-redaktionellen Verantwortung von
Chameleon Pharma Consulting (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
Gerade auch mittelständische Unternehmen sollten heute international nach Möglichkeiten Ausschau halten, um zusätzliche Marktanteile und Zusatzgewinne zu generieren. Da mit dem Launch in den Emerging Markets große Investitionen und Risiken verbunden sind, ist eine gründliche Marktanalyse ratsam
CHAMELEON PHARMA CONSULTING auf der EXPOPHARM ...
Chameleon Pharama Consulting ist ein junges Unternehmen, das sich aber rasch als zuverlässiger und erfolgreicher Partner für die Markterweiterung im Gesundheitsbereich etabliert hat. 60 erfolgreich abgeschlossene Consulting-Projekte in den letzten drei Jahren – diese Zahlen sprechen für sich.
ERBD invests in Russian Pharma Company ...
Since their establishment in 1991 the ERBD has become the largest financial investor in their region of operations which stretches from central Europe and the Western Balkans to central Asia. With the ability and willingness to bear risk on behalf of their clients, in order to help countries in the
Weitere Mitteilungen von Chameleon Pharma Consulting
ERBD invests in Russian Pharma Company ...
Since their establishment in 1991 the ERBD has become the largest financial investor in their region of operations which stretches from central Europe and the Western Balkans to central Asia. With the ability and willingness to bear risk on behalf of their clients, in order to help countries in the
Selling of medicine in Internet is not allowed in Ukraine ...
On December 29, 2011 the Ministry of Health (an organ that provides the introduction of state policy in public health) has put a new law concerning internet sales of medicines and drugs in place. From this date the changes for distribution drugs to patients and consumers are the following: • Di
New innovative retail outlets“ supermarket combined with pharmacies” - opened in the suburbs of Moscow ...
X5 Retail Group N.V. and “Mosoblformatsiya” announced about signing a joint agreement to establish a network of 60 supermarkets combined with pharmacies in the suburbs of Moscow. The Management believes to sell more units per sqm. compared to traditional pharmacy or supermarket outlets. This in
Russian Investors attracted by European Healthcare business! ...
More and more Russian investors and Pharma companies are interested in West- European healthcare and Pharma / OTC targets. Nowadays the CIS and CEE Pharma markets develop very well, mostly above 15-17%. However the markets are still dominated by more than 80% imported products from West-Europe, Asia
